TRDA
Entrada Therapeutics, Inc. · Healthcare
MPM BIOVENTURES 2018, L.P. sold $1.9M of Entrada Therapeutics, Inc.
10% owner
Sold$1,905,768
$7.33Price
259,837Shares
−6%Stake
What TRDA did after the filing
- The stock from Thu, Sep 10 open, $7.00
- −32.4%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Oct 22 close.
Traded Fri, Sep 4. Filed Wed, Sep 9, 7:24 PM ET, after the close. Returns use the Sep 10 open and the Oct 22 close. Not investment advice.